Your browser doesn't support javascript.
loading
Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year results.
Shore, Neal; Kaplan, Steven A; Tutrone, Ronald; Levin, Richard; Bailen, James; Hay, Alan; Kalota, Susan; Bidair, Mohamed; Freedman, Sheldon; Goldberg, Kenneth; Snoy, Frederick; Epstein, Jonathan I.
Afiliação
  • Shore N; Carolina Urologic Research Center, Myrtle Beach, SC, USA. NShore@gsuro.com.
  • Kaplan SA; Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  • Tutrone R; Chesapeake Urology Research Associates, Baltimore, MD, USA.
  • Levin R; Chesapeake Urology Research Associates, Towson, MD, USA.
  • Bailen J; First Urology, Louisville, KY, USA.
  • Hay A; Willamette Urology, Salem, OR, USA.
  • Kalota S; Urological Associates of Southern Arizona, Tucson, AZ, USA.
  • Bidair M; San Diego Clinical Trials, San Diego, CA, USA.
  • Freedman S; Freedman Urology, Las Vegas, NV, USA.
  • Goldberg K; UT Southwestern Department of Urology, Lewisville, TX, USA.
  • Snoy F; Urology Group of New Mexico, Albuquerque, NM, USA.
  • Epstein JI; Johns Hopkins Medical Institutions, Baltimore, MD, USA.
World J Urol ; 38(12): 3101-3111, 2020 Dec.
Article em En | MEDLINE | ID: mdl-32088746

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Neoplasias da Próstata / Fluoracetatos Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Peptídeos / Neoplasias da Próstata / Fluoracetatos Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article